Prevalence of neutralizing antibodies against liver-tropic adeno-associated virus serotype vectors in 100 healthy Chinese and its potential relation to body constitutions

Journal of Integrative Medicine

Volumn 13, Issue 5, 2015, Pages 341-346

  Ling, Chen ^a,b   Wang, Yuan ^c   Feng, Ying Lu ^d   Zhang, Ya Ni ^c   Li, Jun ^c   Hu, Xin Rui ^c,e   Wang, Li Na ^c   Zhong, Mao Feng ^e   Zhai, Xiao Feng ^c   Zolotukhin, Irene ^a   Srivastava, Arun ^a,b   Ling, Chang Quan ^c,f  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d 401 Hospital of PLA   (China)

^e SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^f Information Centre   (China)

Author keywords

body constitutions; medicine, Chinese traditional; neutralizing antibodies; recombinant adeno associated virus vector

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 2; ADENO ASSOCIATED VIRUS 3; ADENO ASSOCIATED VIRUS 8; ADULT; ARTICLE; BODY CONSTITUTION; CHINESE; CHINESE MEDICINE; COHORT ANALYSIS; FEMALE; HUMAN; MALE; NORMAL HUMAN; SEROPREVALENCE; SEROTYPE; VALIDATION PROCESS; VIRUS CAPSID; AGED; BLOOD; CLASSIFICATION; DEPENDOPARVOVIRUS; GENE VECTOR; IMMUNOLOGY; LIVER; MIDDLE AGED; VIROLOGY;

ADULT; AGED; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BODY CONSTITUTION; DEPENDOVIRUS; FEMALE; GENETIC VECTORS; HUMANS; LIVER; MALE; MIDDLE AGED; SEROGROUP;

EID: 85050580206     PISSN: 20954964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2095-4964(15)60200-X     Document Type: Article

References (35)

1. F Mingozzi, KA High Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges Nat Rev Genet 12 5 2011 341 355
2. Y Liu, YJ Kim, M Ji, J Fang, N Siriwon, LI Zhang, P Wang Enhancing gene delivery of adeno-associated viruses by cell-permeable peptides Mol Ther Methods Clin Dev 1 2014 12
3. S Ponnazhagan, P Mukherjee, MC Yoder, XS Wang, SZ Zhou, J Kaplan, S Wadsworth, A Srivastava Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice Gene 190 1 1997 203 210
4. RO Snyder, CH Miao, GA Patijn, SK Spratt, O Danos, D Nagy, AM Gown, B Winther, L Meuse, LK Cohen, AR Thompson, MA Kay Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors Nat Genet 16 3 1997 270 276
5. A Asokan, DV Schaffer, RJ Samulski The AAV vector toolkit: poised at the clinical crossroads Mol Ther 20 4 2012 699 708
6. CS Manno, GF Pierce, VR Arruda, B Glader, M Ragni, JJ Rasko, MC Ozelo, K Hoots, P Blatt, B Konkle, M Dake, R Kaye, M Razavi, A Zajko, J Zehnder, PK Rustagi, H Nakai, A Chew, D Leonard, JF Wright, RR Lessard, JM Sommer, M Tigges, D Sabatino, A Luk, H Jiang, F Mingozzi, L Couto, HC Ertl, KA High, MA Kay Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response Nat Med 12 3 2006 342 347
7. + T-cell responses to adeno-associated virus capsid in humans Nat Med 13 4 2007 419 422
8. GP Gao, MR Alvira, L Wang, R Calcedo, J Johnston, JM Wilson Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy Proc Natl Acad Sci U S A 99 18 2002 11854 11859
9. H Nakai, S Fuess, TA Storm, S Muramatsu, Y Nara, MA Kay Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice J Virol 79 1 2005 214 224
10. AC Nathwani, EG Tuddenham, S Rangarajan, C Rosales, J McIntosh, DC Linch, P Chowdary, A Riddell, AJ Pie, C Harrington, J O'Beirne, K Smith, J Pasi, B Glader, P Rustagi, CY Ng, MA Kay, J Zhou, Y Spence, CL Morton, J Allay, J Coleman, S Sleep, JM Cunningham, D Srivastava, E Basner-Tschakarjan, F Mingozzi, KA High, JT Gray, UM Reiss, AW Nienhuis, AM Davidoff Adenovirus-associated virus vector-mediated gene transfer in hemophilia B N Engl J Med 365 25 2011 2357 2365
11. AC Nathwani, UM Reiss, EG Tuddenham, C Rosales, P Chowdary, J McIntosh, M Della Peruta, E Lheriteau, N Patel, D Raj, A Riddell, J Pie, S Rangarajan, D Bevan, M Recht, YM Shen, KG Halka, E Basner-Tschakarjan, F Mingozzi, KA High, J Allay, MA Kay, CY Ng, J Zhou, M Cancio, CL Morton, JT Gray, D Srivastava, AW Nienhuis, AM Davidoff Long-term safety and efficacy of factor IX gene therapy in hemophilia B N Engl J Med 371 21 2014 1994 2004
12. NR Blacklow, MD Hoggan, WP Rowe Isolation of adenovirus-associated viruses from man Proc Natl Acad Sci U S A 58 4 1967 1410 1415
13. C Zincarelli, S Soltys, G Rengo, JE Rabinowitz Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection Mol Ther 16 6 2008 1073 1080
14. C Ling, Y Lu, JK Kalsi, GR Jayandharan, B Li, W Ma, B Cheng, SW Gee, KE McGoogan, L Govindasamy, L Zhong, M Agbandje-McKenna, A Srivastava Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3 Hum Gene Ther 21 12 2010 1741 1747
15. B Cheng, C Ling, Y Dai, Y Lu, LG Glushakova, SW Gee, KE McGoogan, GV Aslanidi, M Park, PW Stacpoole, D Siemann, C Liu, A Srivastava Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells Gene Ther 19 4 2012 375 384
16. C Ling, Y Wang, Y Zhang, A Ejjigani, Z Yin, Y Lu, L Wang, M Wang, J Li, Z Hu, GV Aslanidi, L Zhong, G Gao, A Srivastava Selective in vivo targeting of human liver tumors by optimized AAV3 vectors in a murine xenograft model Hum Gene Ther 25 12 2014 1023 1034
17. L Lisowski, AP Dane, K Chu, Y Zhang, SC Cunningham, EM Wilson, S Nygaard, M Grompe, IE Alexander, MA Kay Selection and evaluation of clinically relevant AAV variants in a xenograft liver model Nature 506 7488 2014 382 386
18. E Masat, G Pavani, F Mingozzi Humoral immunity to AAV vectors in gene therapy: challenges and potential solutions Discov Med 15 85 2013 379 389
19. R Calcedo, JM Wilson Humoral immune response to AAV Front Immunol 4 2013 341
20. Q Liu, W Huang, C Zhao, L Zhang, S Meng, D Gao, Y Wang The prevalence of neutralizing antibodies against AAV serotype 1 in healthy subjects in China: implications for gene therapy and vaccines using AAV1 vector J Med Virol 85 9 2013 1550 1556
21. Q Liu, W Huang, H Zhang, Y Wang, J Zhao, A Song, H Xie, C Zhao, D Gao Neutralizing antibodies against AAV2, AAV5 and AAV8 in healthy and HIV-1-infected subjects in China: implications for gene therapy using AAV vectors Gene Ther 21 8 2014 732 738
22. S van der Marel, EM Comijn, HW Verspaget, S van Deventer, GR van den Brink, H Petry, DW Hommes, V Ferreira Neutralizing antibodies against adeno-associated viruses in inflammatory bowel disease patients: implications for gene therapy Inflamm Bowel Dis 17 12 2011 2436 2442
23. WP Parks, DW Boucher, JL Melnick, LH Taber, MD Yow Seroepidemiological and ecological studies of the adenovirus-associated satellite viruses Infect Immun 2 6 1970 716 722
24. HD Mayor, S Drake, J Stahmann, DM Mumford Antibodies to adeno-associated satellite virus and herpes simplex in sera from cancer patients and normal adults Am J Obstet Gynecol 126 1 1976 100 104
25. R Calcedo, LH Vandenberghe, G Gao, J Lin, JM Wilson Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses J Infect Dis 199 3 2009 381 390
26. Y Qu, X Nie, Z Yang, H Yin, Y Pang, P Dong, S Zhan The prevalence of hemophilia in mainland China: a systematic review and meta-analysis Southeast Asian J Trop Med Public Health 45 2 2014 455 466
27. CQ Zhao, Y Zhou, J Ping, LM Xu Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities J Integr Med 12 5 2014 401 408
28. LN Wang, Y Wang, Y Lu, ZF Yin, YH Zhang, GV Aslanidi, A Srivastava, CQ Ling, C Ling Pristimerin enhances recombinant adeno-associated virus vector-mediated transgene expression in human cell lines in vitro and murine hepatocytes in vivo J Integr Med 12 1 2014 20 34
29. Q Wang, YB Zhu Epidemiological investigation of constitutional types of Chinese medicine in general population: Base on 21,948 epidemiological investigation data of nine provinces in China Zhonghua Zhong Yi Yao Za Zhi 24 1 2009 7 12 Chinese with abstract in English.
30. A Meliani, C Leborgne, S Triffault, L Jeanson-Leh, P Veron, F Mingozzi Determination of anti-adeno-associated virus vector neutralizing antibody titer with an in vitro reporter system Hum Gene Ther Methods 26 2 2015 45 53
31. Wang M, Crosby A, Hastie E, Samulski JJ, McPhee S, Joshua G, Samulski RJ, Li C. Prediction of adeno-associated virus neutralizing antibody activity for clinical application. Gene Ther. 2015 Jun 30. doi: 10.1038/gt.2015.69. [Epub ahead of print].
32. J Mimuro, H Mizukami, M Shima, T Matsushita, M Taki, S Muto, S Higasa, M Sakai, T Ohmori, S Madoiwa, K Ozawa, Y Sakata The prevalence of neutralizing antibodies against adeno-associated virus capsids is reduced in young Japanese individuals J Med Virol 86 11 2014 1990 1997
33. SL Yao, ZZ Zhang, XS Yang, X Xu, J Cao, GY Xie, Q Zhang Analysis of composite traditional Chinese medicine constitution: an investigation of 974 volunteers J Chin Integr Med 10 5 2012 508 515 Chinese with abstract in English.
34. YB Zhu, Q Wang, CY Wu, GM Pang, JX Zhao, SL Shen, ZY Xia, X Yan Logistic regression analysis on relationships between traditional Chinese medicine constitutional types and overweight or obesity J Chin Integr Med 8 11 2010 1023 1028 Chinese with abstract in English.
35. YB Zhu, Q Wang, KF Chen, YE Wu, WL Hong, L Liu Stratified analysis of the relationship between traditional Chinese medicine constitutional types and health status in the general population based on data of 8 448 cases J Chin Integr Med 9 4 2011 382 389 Chinese with abstract in English.